These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 34493790)

  • 21. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
    Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K
    J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erythrocytosis associated with hyperthyroidism: a rare case report and clinical study of possible mechanism.
    Liu X; Liu J; Fan L; Shi B
    Endocr Res; 2015; 40(4):177-80. PubMed ID: 25775381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response to methimazole in Graves' disease. The European Multicenter Study Group.
    Benker G; Vitti P; Kahaly G; Raue F; Tegler L; Hirche H; Reinwein D
    Clin Endocrinol (Oxf); 1995 Sep; 43(3):257-63. PubMed ID: 7586593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short-term effects of β-adrenergic antagonists and methimazole in new-onset thyrotoxicosis caused by Graves' disease.
    Tagami T; Yambe Y; Tanaka T; Tanaka T; Ogo A; Yoshizumi H; Kaise K; Higashi K; Tanabe M; Shimazu S; Usui T; Shimatsu A; Naruse M;
    Intern Med; 2012; 51(17):2285-90. PubMed ID: 22975536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-partum and non-post-partum relapsing Graves' hyperthyroidism display different response to anti-thyroid drugs.
    Rotondi M; Capelli V; Coperchini F; Pinto S; Croce L; Tonacchera M; Chiovato L
    Eur J Endocrinol; 2018 Jun; 178(6):589-594. PubMed ID: 29559498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TSH receptor antibody measurements and prediction of remission in Graves' disease patients treated with minimum maintenance doses of antithyroid drugs.
    Okamoto Y; Tanigawa S; Ishikawa K; Hamada N
    Endocr J; 2006 Aug; 53(4):467-72. PubMed ID: 16820704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term follow-up of patients with hyperthyroidism due to Graves' disease treated with methimazole. Comparison of usual treatment schedule with drug discontinuation vs continuous treatment with low methimazole doses: a retrospective study.
    Mazza E; Carlini M; Flecchia D; Blatto A; Zuccarini O; Gamba S; Beninati S; Messina M
    J Endocrinol Invest; 2008 Oct; 31(10):866-72. PubMed ID: 19092290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term Methimazole Therapy in Juvenile Graves' Disease: A Randomized Trial.
    Azizi F; Takyar M; Madreseh E; Amouzegar A
    Pediatrics; 2019 May; 143(5):. PubMed ID: 31040197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease.
    Takata K; Amino N; Kubota S; Sasaki I; Nishihara E; Kudo T; Ito M; Fukata S; Miyauchi A
    Clin Endocrinol (Oxf); 2010 Jun; 72(6):845-50. PubMed ID: 19912243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimation of antithyroid drug dose in Graves' disease: value of quantification of thyroid blood flow with color duplex sonography.
    Saleh A; Fürst G; Feldkamp J; Godehardt E; Grust A; Mödder U
    Ultrasound Med Biol; 2001 Aug; 27(8):1137-41. PubMed ID: 11527601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism.
    Hashizume K; Ichikawa K; Sakurai A; Suzuki S; Takeda T; Kobayashi M; Miyamoto T; Arai M; Nagasawa T
    N Engl J Med; 1991 Apr; 324(14):947-53. PubMed ID: 1900575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thyroid vascularization by color doppler ultrasonography in Graves' disease. Changes related to different phases and to the long-term outcome of the disease.
    Baldini M; Castagnone D; Rivolta R; Meroni L; Pappalettera M; Cantalamessa L
    Thyroid; 1997 Dec; 7(6):823-8. PubMed ID: 9459623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease.
    Rittmaster RS; Zwicker H; Abbott EC; Douglas R; Givner ML; Gupta MK; Lehmann L; Reddy S; Salisbury SR; Shlossberg AH; Tan MH; York SE
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3283-8. PubMed ID: 8784084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of Jiakangning Capsule on Thyroid Function and Akt/mTOR Signal Pathway of Graves' Disease Mice: an Experimental Study].
    Li QM; Wei JP; Li M; Meng SH
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Sep; 35(9):1119-24. PubMed ID: 26591370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
    Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
    Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.
    Ohara N; Kaneko M; Kitazawa M; Uemura Y; Minagawa S; Miyakoshi M; Kaneko K; Kamoi K
    J Med Case Rep; 2017 Feb; 11(1):32. PubMed ID: 28162094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of thyroxine administration on serum thyrotropin receptor antibody and thyroglobulin levels in patients with Graves' hyperthyroidism during antithyroid drug therapy.
    Kuo SW; Huang WS; Hu CA; Liao WK; Fung TC; Wu SY
    Eur J Endocrinol; 1994 Aug; 131(2):125-30. PubMed ID: 8075781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of the IL-23/IL-17 axis in the pathogenesis of Graves' disease.
    Zheng L; Ye P; Liu C
    Endocr J; 2013; 60(5):591-7. PubMed ID: 23327801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of anti-thyroid drugs in euthyroid pregnant women with previous Graves' disease.
    McNab T; Ginsberg J
    Clin Invest Med; 2005 Jun; 28(3):127-31. PubMed ID: 16021986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical features of primary hyperthyroidism caused by Graves' disease admixed with resistance to thyroid hormone (P453T).
    Sato H
    Endocr J; 2010; 57(8):687-92. PubMed ID: 20574139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.